Concepedia

Chandni Valiathan

CV

Statistics

Publications

7

Citations

422

H-Index

7

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

Center for Environmental Health

Chandni Valiathan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

2007–2021

7

Publications

7

Activation of Inflammation/NF-κB Signaling in Infants Born to Arsenic-Exposed Mothers

Rebecca C. Fry, Panida Navasumrit, Chandni Valiathan et al. · PLoS Genetics · 2007 · 255 citations · Full text

, , +17

Genomic predictors of interindividual differences in response to DNA damaging agents

Rebecca C. Fry, J. Peter Svensson, Chandni Valiathan et al. · Genes & Development · 2008 · 68 citations · Full text

, , +15

P4‐036: Pharmacokinetics and Pharmacodynamics to Support Clinical Studies of MK‐8719: an O‐Glcnacase Inhibitor for Progressive Supranuclear Palsy

Punam Sandhu, Junghoon Lee, Jeanine Ballard et al. · Alzheimer s & Dementia · 2016 · 26 citations

, , +14

Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir

Rajesh Krishna, Lilly East, Patrick Larson et al. · Journal of Pharmacy and Pharmacology · 2016 · 25 citations

, , +15

A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects

Chandni Valiathan, José L. McFaline‐Figueroa, Leona D. Samson · DNA repair · 2011 · 22 citations · Full text

, , +14

1–5 of 7